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Stem cell activation and development is central to skeletal development, maintenance, and repair, as it is for all tissues. However, an
integrated model of stem cell proliferation, diﬀerentiation, and transit between functional compartments has yet to evolve. In this
paper, the authors review current concepts in stem cell biology and progenitor cell growth and diﬀerentiation kinetics in the context
of bone formation. A cell-based modeling strategy is developed and oﬀered as a tool for conceptual and quantitative exploration
of the key kinetic variables and possible organizational hierarchies in bone tissue development and remodeling, as well as in tissue
engineering strategies for bone repair.
THE PARADIGM OF STEM CELLS AND
PROGENITOR CELLS
Stem cells and progenitors are essentially present in
all normal tissues [1, 2, 3, 4, 5, 6, 7]. “Stem cells” are de-
ﬁned, in general, as resting cells (not actively proliferat-
ing) that are present in small numbers in normal tissues.
They share one important feature: the capacity for “asym-
metric” cell division and “self-renewal” [8, 9]. In this pro-
cess, a stem cell is activated by some signal or event to
leave its normal resting state and to divide. However, the
result of this cell division provides two daughter cells that
are not identical. One daughter cell proliferates symmet-
rically, often for many cell divisions, to produce an abun-
dance of progeny referred to as progenitors. These pro-
genitors subsequently diﬀerentiate to form a mature tis-
sue. In contrast, the second daughter cell returns to the
originalrestingstateofthemothercelluntilanewactivat-
ing signal or event occurs. It retains a stem cell phenotype
and all of the capabilities of the original mother cell in a
process referred to as “self-renewal.” This process is criti-
cally important to the preservation of the stem cell com-
partment. If both daughter cells were to become progeni-
tors,thenthepoolofstemcellswouldbeprogressivelyde-
pletedwitheachactivationevent.Suchanoutcomewould
rapidly deplete the stem cell population that is necessary
to support ongoing tissue remodeling and repair required
for long-term health.
During embryonic development, cells of the inner
mass of the blastocyst retain the capability to regenerate
an entire individual, and are therefore “totipotent” in
their diﬀerentiation potential. However, convention has
held that as the progeny of these totipotent stem cells
become dispersed throughout the organism and localized
within speciﬁc tissues or organs, the stem cells in each
of these tissues become progressively determined and
conﬁned transiently or permanently within deﬁned
stem cell compartments or niches. Stem cell populations
initially become committed as “pleuripotent” stem cells
conﬁned to selected groups of tissues within a devel-
oping embryo (endoderm, ectoderm, or mesoderm).
As development proceeds, some stem cell populations
may remain “multipotent,” capable of diﬀerentiation
along one of several cell lineages (eg, cell populations
in the neural tube, neural crest cells, hemangioblasts,
and the mesenchymal mass of fetal limb buds). Other
stem cell populations become intrinsically limited to the
generation of only one mature cell type (eg, intestinal
endothelium or skin keratinocytes). Such monopotent or
unipotent stem cells were considered to be “committed,”
“restricted,” or “determined” as a result of irreversible
changes in the cell nucleus.
The transient pleuripotent and multipotent stem cell
populations of embryonic and fetal life have appeared to
disappear in postnatal life, leaving behind populations of
more restricted adult stem cells that support virtually ev-
ery organ system (eg, skin, intestinal mucosa, liver, vascu-
lar endothelium, the central nervous system, hematopoi-
etic stem cells in bone marrow, and connective tissue or
mesencymal stem cells) [1, 2, 3, 4, 5, 6, 7]. These adult
stem cell populations are of central importance in adult
health and in all settings requiring tissue repair, remod-
eling, or regeneration. In fact, the health of a given tis-
sue might even be deﬁned by the state and kinetics of
the supporting infrastructure of stem cells and progeni-
tors.2003:3 (2003) Connective Tissue Stem Cell Kinetics 171
The progressive restriction of stem cells from embry-
onic stem cells, to fetal stem cells to adult stem cells, to
terminally diﬀerentiating cells, and to eventual cell death
can be seen as a series of progressive transitions as cells
move from one deﬁned population to another. Cell pro-
liferation is an integral part of this process. The period of
residence or life-span of cells within each compartment
or the process of transition or “transit” between compart-
ments is often associated with cycles of cell division, and
proliferation is not always followed by terminal diﬀeren-
tiation. The dramatic and rapid expansion of tissue mass
and stem cell diversity that is associated with embryonic
development, as well as fetal and postnatal growth, also
requires expansion of stem cell populations as much as
diversiﬁcation. Therefore, stem cells must not be limited
to only asymmetric cell division. Stem cell expansion re-
quires “symmetric” stem cell division or “self-expansion,”
as discussed below.
Challengestothetraditionalstemcellparadigm
In recent years, a number of lines of observation have
challengedsomeofthetraditionalviewsoflineagerestric-
tion among adult stem cell pools. For example, cloning by
transfer of somatic nuclei into activated oocytes provides
evidencethattheapparentrestrictionofsomaticcellsmay
be regulated by factors that are extrinsic to the nucleus
[10]. However, the mechanism of reversibility induced by
the cytoplasmic environment of an activated oocyte may
n o tb er e l e v a n tt oe v e n t si nn o r m a ls t e mc e l lp h y s i o l o g y .
Of more physiologic relevance, are a number of ob-
servations that suggest that adult mammals may retain
one or more stem cell populations which either retain the
multipotent or pleuripotent biological potential or can
be induced to exhibit such potential. Several reports have
demonstrated that, following transplantation of marrow-
derived cells or enriched marrow-derived hematopoi-
etic stem cells (HSC), donor-derived cells can be de-
tected contributing to hepatocyte and biliary epithelium
[11, 12, 13], cardiac myocytes [14, 15], skeletal myocytes
[16, 17], lung, intestinal, and skin epithelium [18], and
neuroectoderm [19, 20, 21, 22]. Others have shown that
neural-derived [23, 24]o rm u s c l e - d e r i v e d[ 25, 26]c e l l s
cancontributeto hematopoiesis. Similarly, severalreports
have demonstrated that culture-expanded bone marrow-
derived cells [27] may contribute to a broad range of tis-
sues [28, 29], such as skeletal muscle [29, 30], cardiac
muscle [31, 32], liver [12, 33, 34], intestinal mucosa [35],
lung [36], vascular endothelial cells [37, 38, 39, 40], bone
and cartilage [41, 42], glial and neuronal tissues [43, 44],
and other sites [45]. Multipotentiality has also been re-
ported in cells derived from muscle [46, 47]a n df a t[ 7].
Most recently, a multipotent adult progenitor cell
(MAPC) has been proposed [18], based on evidence that
some cells from adult marrow can be expanded for over
80 population doublings, and if transplanted into a blas-
tocyst will contribute to the tissue of all three germ lay-
ers.Furthermore,theseauthorsreportthatcellsexpanded
in this way can be infused into a mouse host and can be
f o u n dt oe n g r a f ta n dc o n t r i b u t et ob l o o d ,b o n em a r r o w ,
spleen as well as epithelium in lung, liver, and intestine.
These results all suggest that adult mammals may re-
tain one or more populations of adult progenitor cells
that retain the intrinsic biological potential to generate
progeny which can potentially diﬀerentiate into many en-
dodermally, mesodermally, and/or ectodermally derived
mature tissues. However, several possible mechanisms
could contribute to these observations. One possibility is
that a small number of intrinsically multipotential cells
may persist in marrow and other tissue niches. These cells
might be quiescent in adults or may function upstream of
more easily identiﬁed stem cell pools. If so, they might
be present in very low abundance and function with a
very low turnover rate and still feed into or supplement
more restricted downstream adult stem cell populations.
It is also possible that the apparent restriction of most, if
not all, stem cells in marrow and in other tissues, may be
imposed by factors extrinsic to the stem cell. The stem cell
niche and milieu within each organ system may deﬁne the
phenotype(s) expressed by the local stem cell pool, as a
result of the unique signaling environment from the local
matrix, cytokines, and cell-cell interactions in each tissue.
Changing the niche of a stem cell pool, by transplanta-
tion into a new niche or exposing a stem cell to unique
tissue culture conditions, may unmask a broader intrin-
sic biological potential. Finally, it is possible that the ob-
served properties of a stem cell pool might be changed
through selective pressures that exist during prolonged in
vitro culture or during radical procedures such as trans-
plantation.
Regardlessofthemechanism(s)thatareatwork,these
recent observations are of tremendous interest for those
who would seek to develop stem cell therapy strategies us-
ingadultcells[48].Allofthediversestemcellpopulations
thatresideinorcanbederivedfromadulttissueshavepo-
tential value in therapeutic eﬀorts to regenerate, preserve,
or repair tissues. This fact also presents a challenge to the
stem cell ﬁeld to deﬁne practical strategies for character-
izing and modeling the kinetics of stem cell function and
various stem cell populations during normal tissue for-
mation and remodeling, as well as in settings of repair.
These models must include means of accommodating ad-
ditional and as yet uncharacterized pools of stem cells as
well as more ﬂuid relationships between stem cell pools
than have previously been recognized.
Recognizing this need, this paper presents the ratio-
nale for and development of a practical model system
relevant to investigation of the kinetics of the stem cell
populations contributing to the formation and remod-
eling of bone tissue. The conceptual starting point for
this discussion is the relatively traditional vision of the
life cycle of a stem cell and its progeny; it is illustrated
in Figure 1. In this model, functionality of stem cell and
its progeny is regulated by ﬁve primary events or behav-
iors: activation, proliferation, migration, diﬀerentiation,
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then further developed to incorporate strategies that ac-
commodate concepts of multiple stem cell pools or tran-
sit populations and the relationships between these stem
cells and transit cell pools.
Boneformationandtheconnectivetissue
stemcellsystem
Backgroundandterminology
In the 1960s, Burwell showed that the bone forma-
tion induced by implantation of cancellous bone grafts
was derived from primitive osteogenic cells in bone mar-
row [49, 50, 51]. Friedenstein et al [52] showed that new
bone was formed by proliferative ﬁbroblast-like marrow
cells and that the number of these proliferative cells could
be assayed by counting the number of ﬁbroblastic colony
forming units (CFU-Fs) in vitro. It was later shown that,
atleastsomeofthesecolonyformingcellsaremultipotent
and can diﬀerentiate into bone, cartilage, ﬁbrous tissue,
fat, or muscle [41, 42]. Several reviews nicely summarize
themanycontributionsinthisﬁeld[42,53,54,55,56,57].
Many names have been used to describe the colony
forming cells found in bone marrow, periosteum, or tra-
becular bone, in addition to CFU-Fs. These terms include
mechanocytes,bonemarrowstromalcells,andmesenchy-
mal stem cells, although the precise deﬁnition and bio-
logic capabilities ascribed by these terms are not entirely
synonymous. A large subset of the colony forming popu-
lation has been suggested to be resident in tissue in a qui-
escent(Go)stateinvivo,supportingtheconceptthatthese
cellsmayhavestemcell-likefunctionandself-renewalpo-
tential [58].
We have previously proposed and provided the ratio-
nale for the term connective tissue progenitors (CTPs) for
the heterogeneous population of proliferative cells that
can be harvested from bone marrow and other tissues,
and can be shown to diﬀerentiate into one or more con-
nective tissue phenotypes [59]. (See Figure 2.) We use the
term CTP throughout the following discussion. This term
recognizes that these tissue-derived cells are not a pure or
uniform population, and may be derived from more than
one pool of stem cells and progenitors in native tissues.
Thesecellsmayincludetruerestingmultipotentstemcells
that become activated after harvest and are capable of
self-renewal. However, colonies may also be formed by
cells that are already proliferating in vivo, that lack self-
renewal capabilities and may exhibit intrinsic commit-
ment to various stages of diverse lineages [53, 57, 60].
Thisdiversitycanbeasourceoffrustrationforthoselook-
ing for homogeneous puriﬁed populations of cells. How-
ever, this diversity can also be a source of valuable in-
formation which can be dissected experimentally using
in vitro CFU assays to understand variation in intrinsic
properties, the prevalence and kinetics of various con-
nective tissue stem cell populations, and how these pop-
ulations change with aging, gender, disease states, phar-
macologic intervention, and tissue engineering strategies
[59, 61, 62, 63].
Adultconnectivetissueprogenitorpopulations
Multipotent CTPs are resident in many musculoskele-
tal locations. The osteogenic and chondrogenic potential
of periosteum, as recognized long ago [64], is derived
from cells resident in the outer cambial layer of perios-
teum [65, 66, 67]. Multipotent CTPs are present on the
surface of bone trabeculae, in peritrabecular soft tissues,
within haversian canals of cortical bone, and in the bone
marrow space, including bone marrow harvested by aspi-
ration [62] .R e c e n t l y ,C T P sh a v ea l s ob e e nd e m o n s t r a t e d
to be resident in adipose tissue [7, 68] and muscle [46].
A potentially unifying concept to explain the presence
of CTPs in fat, muscle, and other tissues is the presence
in each of vascular pericytes. The pericyte, a unique cell
found outside the basement membrane of small blood
vessels, is present in all vascularized tissues. Several inves-
tigators have found that pericytes isolated from many tis-
sues can be induced to diﬀerentiate into various connec-
tive tissue phenotypes [69, 70], suggesting that pericytes
may represent a widely distributed population of mul-
tipotent CTPs. In bone marrow, pericytes may give rise
to the Westen-Bainton cells, ﬁbroblast-like marrow stro-
mal cells associated with the outer surface of marrow si-
nusoids expressing alkaline phosphatase [71]. Bianco et
al [72, 73, 74] have suggested that pericytes and Westen-
Bainton cells are part of an integrated system of stem
and progenitor cells in bone marrow. They argue that
these two cell types contribute to the formation of the
ﬁbroblastic stromal network in marrow that supports
hematopoiesis and to the formation and remodeling of
m a r r o wf a ta sw e l la so fc o r t i c a la n dt r a b e c u l a rb o n e
(Figure 3). However, the pericyte alone does not account
for all the progenitors outside bone. Satellite cells har-
vested by digestion of isolated skeletal muscle ﬁbers can
undergo connective tissue diﬀerentiation independent of
the pericyte population [6, 75].
The widespread distribution of multipotent CTPs is
particularly relevant to the ﬁeld of orthopedic tissue engi-
neering. It provides many potential sources of stem cells
and progenitors that can be harvested, selected, concen-
trated, and manipulated or “engineered” to improve clin-
ical outcomes. This system also provides many potential
biologic targets for specialized matrix materials and lo-
cally or systemically active pharmaceuticals, hormones,
growth factors, and cytokines. Moreover, it oﬀers a fer-
tile system in which to explore possible intrinsic diﬀer-
ences between CTPs in these disparate and distinct stem
cell/progenitor cell compartments, as well as the unique
features of the stem cell niches within each compartment.
THE MATRIX-BASED MODEL FOR BONE TISSUE
FORMATION AND REMODELING
A remarkable set of histologic observations and
the application of innovative and painstaking methods
of quantitative histomorphometry pioneered by Parﬁtt
and Frost have provided a robust understanding of the2003:3 (2003) Connective Tissue Stem Cell Kinetics 173
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Figure 1. Six stages in the stem cell life cycle. In the simplest scenario, the life cycle of cells in a stem cell system involves at least six
stages. This begins with the cycle of stem cell activation and cell division producing a progenitor cell and self-renewal of the stem cell,
but is continuous with the process of proliferation of progenitors, migration, diﬀerentiation, and eventual apoptosis or cell death.
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Figure 2. Diﬀerentiation pathways for connective tissue progenitors. This diagram illustrates the potential diﬀerentiation pathways
available to connective tissue progenitor cells. Some of the transcription factors that regulate these pathways are shown in associated
boxes.
functional and dynamic parameters associated with bone
formation and remodeling at the tissue level [76, 77, 78,
79, 80]. In adult bone remodeling, these processes of bone
formation and bone resorption generally take place in the
context of the basic multicellular unit (BMU) described
byFrost[81].AconceptualillustrationofoneBMUispre-
sented in Figure 3.
In an averageBMU, a group of 6–10 osteoclasts moves
forward resorbing bone at a linear rate of approximately
20–40µm per day. This group of osteoclasts constitutes
a “cutting cone” and will continue to erode bone for a
period of as long as 100 days. The deepest point in the
eroded surface marks the trailing edge of the osteoclast
front, and is usually about 200µm behind the ﬁrst osteo-
clast.
The wave of bone resorption is followed immedi-
ately by a wave of bone formation that is mediated by
osteoblasts. Osteoblasts are rapidly added to the newly
eroded bone surface very near the trailing edge of the os-
teoclast front at a rate that is suﬃcient to cover the surface
ofthenewlyerodedbone.Osteoblastsbeginsecretingma-
trix within a day, and matrix synthesis increases over sev-
eral days to a maximum rate of approximately 1.5µmp e r
day over an area of approximately 150µm2 per osteoblast,
resulting in a maximal rate of synthesis of approximately
225µm3 per day per osteoblast. The wave of osteogene-
sis ﬁlls in the defect created by the osteoclasts, a depth
of about 40–60µm, over a period of about 50 days. The
total matrix synthesis per osteoblast is therefore approxi-
mately6000–9000µm3,or3–5timesitscellvolume.Areas
of increased osteoblast density (smaller surface area per
osteoblast) are associated with proportionately increased
linearratesofmatrixsynthesis[82].InafullyactiveBMU,
approximately2000activeosteoblastswillbeassembledas
a functional unit behind the bone resorption front, trail-
ing over a distance of 1600–2000µm.174 George F. Muschler et al 2003:3 (2003)
Figure 3. Schematic diagram of the osteoblastic stem cell sys-
tem. This conceptual drawing illustrates the primary candidate
populations of stem cells and transit cells thought to be asso-
ciated with bone formation and remodeling. Vascular pericytes
(green), Westen-Bainton cells (orange), type I or pre-osteoblasts
(pink), secretory osteoblasts (maroon), osteocytes (brown), lin-
ing cells (purple), and adipocytes (yellow). Vascular pericytes
may give rise to the Westen-Bainton cells. Pericytes and Westen-
Bainton cells may contribute to the formation of pre-osteoblasts
and also adipocytes. New osteoblast are added in the region im-
mediately behind the advancing front of osteoclastic resorption.
Secretory osteoblasts produce new bone matrix until they be-
come quiescent on the surface of bone as a lining cells (purple)
or become embedded in the matrix as osteocytes (brown), or
die via apoptosis. Osteoclast formation is also illustrated. A frac-
tion of the monocytes population in systemic circulation (blue)
will become resident in the bone marrow space. Osteoclasts are
formedbyfusionofmonocytesresidentinbonemarrowtoform
multinucleated functional units. The nuclei in active osteoclasts
continue to be turned over as a result of nuclear loss and on-
going fusion events with new marrow-derived monocytes [103].
The black arrow indicates the direction of bone resorption by
t h eo s t e o c l a s t i cf r o n t ,f o l l o w e db yb o n ef o r m a t i o n .
During the process of bone formation, some os-
teoblasts become embedded in the newly synthesized ma-
trix as osteocytes. These osteocytes reside within cavi-
ties known as lacunae and interconnect with one another
through multiple processes extending through an inter-
connected plexus of channels called canaliculi. Some os-
teoblasts also undergo apoptosis. The osteoblasts remain-
ing on the bone surface gradually cease making new ma-
trix and spread out as lining cells to occupy a surface
area of approximately 2500µm2, or about 16 times the
area of a secretory osteoblast. Therefore, the mean life-
span of an osteoblast is slightly less than the 50 days
needed to complete the wave of bone formation, proba-
bly about 40 days. However, published estimates of mean
osteoblast life-span vary widely from 10 to 100 days
[59, 83, 84].
In contrast, both the lining cells and the osteocytes
created in this process appear to survive for a long period,
usually until the next wave of bone remodeling moves
through the region. The mean life-span of osteocytes has
been estimated to be 15 years in cancellous bone (∼ 5000
days) [85] and 25 years in cortical bone (∼ 9000 days)
[86, 87], with a range of 3 to 30 years (1000–10,000 days).
However,osteocytescanbelostbeforeremodelingoccurs,
leaving lacunae empty through processes of osteonecrosis
or micropetrosis [88].
In general, after skeletal maturity, bone formation
does not occur without the prior stimulus of bone resorp-
tion. Therefore, the gain or loss of bone in a region of
tissue is dependent primarily on the balance of resorp-
tion and formation in the individual BMUs. However,
new bone formation can occur without bone resorption
on periosteal surfaces and occasionally within nonbone
sites in soft tissues (heterotopic bone formation) and even
in perivascular tissues (Gorski JP and Midura RJ, unpub-
lished data).
The number of BMUs within any region of bone tis-
sue will depend on the rate of activation events in that tis-
suevolume,andvarieswidelyfromregiontoregion,bone
to bone, and individual to individual, but can be esti-
mated using techniques of ﬂuorochrome double labeling,
described ﬁrst by Frost [78]. The number of osteoblasts
per unit volume of bone will also vary widely, but can be
estimated based on measurements of the surface to vol-
ume ratio in the region of interest, the area fraction of the
surface that is occupied by osteoblasts, and the mean area
of an osteoblast. Similarly, the number of osteocytes per
unit volume can be estimated based on the volume frac-
tion of bone in a region and the mean osteocyte density in
the region.
Datawithrespecttoosteocytedensity(Do)isa vailable
with increasing precision. An age-related decline in osteo-
cyte viability was observed long ago [87], as well as the
possibility that many canaliculi and some empty lacunae
may become ﬁlled with mineralized debris (micropetro-
sis) [87]. A study of iliac cancellous bone samples taken
from skeletally healthy white women (age 20–73), found
no evidence of age-related changes in osteocyte density
near the surface of bone (< 25µm), while an age-related
decline was seen in deeper regions in bone [89].
The osteocyte density (Do)i sr e p o r t e dt ob eg r e a t e ri n
cancellous bone (0.000047 osteocytes/µm3)[ 90] than in
cortical bone (0.000026 osteocytes/µm3)[ 91]. Estimates
of osteocyte density as low as 0.000013 osteocytes/µm3
havebeenreportedinthehumaniliaccrest[92]andithas
been suggested that osteocyte density may be increased in
the setting of osteoporosis [93, 94]. However, as a ﬁrst ap-
proximation, based on a mean bone volume of 11 to 25%
incancellousbone,onecanestimatethenumberofosteo-
cytes in one cubic centimeter of cancellous bone to be in
the range of 5 to 10 million.
A concise review of these concepts and mechanisms
involved in the regulation of cellular activity in bone
remodeling has been provided recently by Manolagas
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A THEORETICAL CELL-BASED MODEL FOR BONE
TISSUE FORMATION AND REMODELING
Available knowledge of the likely stem cell and pro-
genitor cell populations in bone and the biologic path-
ways that are available to progenitors of osteoblasts and
osteoclasts provides a useful structure in which to ex-
plore the biologic events using a cell-based approach, fo-
cusing on the key variables in stem cell kinetics associ-
ated with bone remodeling. A cell-based approach has
been the starting point for many other stem cell systems
where the volume of matrix and matrix turnover does not
dominate organ function. However, application of these
strategies in the skin, intestinal mucosa, and the carti-
laginous growth plate in long bones has been facilitated
by the relative ease of histologic assessment in these sys-
tems,thelimited number ofcelltypes inthesetissues,and
the close physical proximity of the stem cell compartment
and maturing cells in these systems [95, 96, 97, 98, 99,
100].
A cell-based mathematical model system requires a
functional understanding of the stem cell and progen-
itor cell populations in the system in order to gener-
ate a mathematical strategy that has ﬁdelity to the ob-
jective hierarchy and kinetic parameters governing the
cell populations involved. The cellular heterogeneity and
three-dimensional complexity of bone have hindered
this kind of investigation in bone. However, the ex-
tensive literature in bone morphology and the estab-
lished matrix-based model for the kinetics of bone ma-
trix turnover, provide a robust set of data and parameters
that facilitate this approach, despite its apparent complex-
ity.
Exploration using a cell-based strategy is necessary in
order to provide insight into the kinetics of stem cell and
progenitor cell populations upstream and downstream of
osteoblasts and osteoclasts. This approach will also be
critical as a platform for rational analysis of the CTP pop-
ulation present in bone and other tissues, for understand-
ing the response of CTPs tissue in injury and repair, and
in the rational design of strategies to use CTPs therapeu-
tically to augment or induce the repair and regeneration
of bone and other tissues.
In a previous publication, we introduced a cell-based
modeling strategy for bone formation, and applied this
model to explore the likely range of some kinetic pa-
rameters in the setting of bone grafting and bone re-
modeling [59]. In this paper, we expand upon this ap-
proach to further explore key variables in bone forma-
tion and remodeling, and particularly the relationship be-
tween stem cell pools in bone and the transit of cells
from one pool to another. Although the discussion be-
low is particularly focused on bone, it is expected that
similar concepts will apply to the regeneration or re-
pair of any tissue that might be derived from connec-
tive tissue stem cells and CTPs, and may also ﬁnd ap-
plication in modeling of stem cell pools in other organ
systems.
Tissueformationandremodeling
In any region of tissue regeneration, repair, or remod-
eling, the quantity of new tissue formed (T) will represent
the diﬀerence between the amount of tissue formed (F)
and the amount of tissue simultaneously lost due to re-
sorption or removal (R):
T = F −R. (1)
This balance between formation and resorption of
bone in an idealized system of tissue remodeling is a cen-
tral theme in the pathogenesis of age-related bone loss
and postmenopausal osteoporosis. Similarly, the balance
oftissueformationortherateoftissueformation(orloss)
can be represented as diﬀerence between the rate of tissue
formation and the rate of tissue loss:
dT
dt
=
dF
dt
−
dR
dt
. (2)
Under steady state conditions, the rate of formation will
equal the rate of resorption and there will be no net
changeintheamountoftissuepresentovertime(dT/dt =
0). Furthermore, the total amount of any given tissue
within an organism at any time will equal the integral of
dT/dt over the life of the organism (0 to t ), beginning at
the fertilized egg.
Bonetissueformation
All bone formation occurs as the result of work
performed by active mature osteoblasts. Taking this
paradigm,therateofbonetissueformationwithinagiven
tissue volume (dFb/dt) can be represented as the product
of the total number of active osteoblasts in that volume
(Nob) and the mean rate of bone tissue formation per cell
(dσob/dt), in units of volume (both bone matrix plus the
volume of osteocytes and canaliculi) per unit time:
dFb
dt
= Nob
dσob
dt
. (3)
Under steady state conditions, the number of active
osteoblasts in a region (Nob) of tissue will be determined
by the rate at which osteoblasts are formed in this region
(Nob/dt) and the mean life-span of an osteoblast (lob)i n
that region, where
Nob =
Nob
dt
lob. (4)
Furthermore, under steady state conditions, the mean
amountofbonematrixproducedbysingleosteoblastdur-
ingitslifetime(σob)canbeexpressedastheproductofthe
mean rate of bone formation per osteoblast and the mean
life-span of an active osteoblast:
σob =
dσob
dt
lob. (5)
This strategy has practical utility. Since histomorpho-
metric measurements can be used to directly measure the
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and to estimate the amount of bone matrix formed per
osteoblast [101], allowing the mean life-span of an os-
teoblast to be calculated [76, 77, 78, 79, 80, 84, 102]. With
the addition of reliable means of directly measuring the
total number of osteoblasts within a tissue region, the rate
of formation of new osteoblasts in the region (Nob/dt)
could be readily estimated.
Tissueremoval
The same approach can be taken to describe the re-
moval of bone tissue, mediated by osteoclastic bone re-
sorption. The rate of bone resorption can be expressed as
dR
dt
= Noc
dσoc
dt
, (6)
where Noc is the number of active osteoclasts and dσoc/dt
is the mean rate of bone resorption for an osteoclast, and
the number of active osteoclasts is determined by the re-
lationship:
Noc =
Noc
dt
loc, (7)
whereNoc/dt is the rate of formation of osteoclasts and loc
is the mean life-span of an osteoclast.
Overallbalanceofbonetissueformation
Substituting values from (3), (4), (6), and (7) into (2)
provides a representation of the overall rate of bone tissue
mass in any tissue volume as
dT
dt
=

Nob
dt
lob

dσob
dt
−

Noc
dt
loc

dσoc
dt
. (8)
Based on this model, the balance of bone tissue for-
mation is dependent on only the rate of formation of os-
teoblasts and osteoclasts, the life-span of osteblasts and
osteoclasts, and the rate of bone formation or resorption
of bone tissue per osteoblast or osteoclast, respectively.
This strategy provides the opportunity to explore the pos-
sible range of variation in these parameters, and to deﬁne
those parameters that are likely to be most important, or
that exert greatest eﬀects on variation in bone formation
and removal.
Many variables will inﬂuence the life-span of these
cells (lx) and the rate or eﬃciency with which they form
or remove matrix (σx). However, these variables are func-
tions of mature cells, therefore they are outside of the fo-
cus of this paper, which is stem cell kinetics. Therefore,
the remainder of this discussion will focus on dissect-
ing the variables related to the rate of formation of os-
teoblasts(Nob/dt),andtherateofformationofosteoclasts
(Noc/dt).
Therateofformationofnewosteoblasts
Inapreviouspublication, weproposed and developed
the rationale for a mathematical model to describe the
rate of osteoblast formation (Nob/dt) under steady state
conditions [59]. This relationship is expressed as
Nob
dt
= Nshε2µPob. (9)
For the purposes of this paper, it is desirable to use
nomenclature that clearly distinguishes between connec-
tive tissue stem cells (CTS) and the HSC that give rise to
osteoclasts. Therefore, we oﬀer a modiﬁed nomenclature,
as follows:
Nob
dt
= NCTShCTSεCTS2µ
CTSPob, (10)
where
(i) both Ns and NCTS = the number of cells in the stem
cell pool upstream of the osteoblast,
(ii) h = the frequency of stem cell activation events in
the deﬁned tissue volume,
(iii) ε = the eﬃciency of stem cell activation events in
the deﬁned tissue volume,
(iv) µ = the eﬀective number of symmetric mitotic cy-
cles between the time of stem cell activation and
thetimeofdiﬀerentiationintomaturesecretoryos-
teoblasts.
The factor Pob represents the cumulative probability
thattheprogenyofaninitialstemcellactivationwouldre-
tainanosteoblasticphenotypeduringtheperiodofclonal
expansion:
Pob = ρob1ρob2ρob3 ···ρobx, (11)
where ρobx = the probability after each mitotic cycle “x”
that the progeny created will retain osteoblastic potential.
The application of this equation to the progeny and com-
mitment events of one hypothetical stem cell is shown in
Figure 4.
It is useful to note that under ideal circumstances, ρob
w i l lb ee q u a lt o1 . 0f o re a c hs e q u e n t i a ls y m m e t r i c a lm i t o -
sis and therefore Pob will equal 1.0. However, this prob-
ability will be reduced by the fraction of progeny after
any mitotic event that undergo apoptosis, or the fraction
of cells that irreversibly commit to an alternative mature
phenotype(eg,anadipocyte).Thecontributionofanyin-
cremental increase in the number of symmetric mitoses
(µ) to additional osteoblast formation depends on main-
taining a value for ρob that is greater than 0.5. Similarly,
few osteoblasts will be formed unless the overall value of
Pob remains substantially greater than 2−µ.
It is also useful to note that product of εh can also be
represented as the activation rate (AR) or the inverse of
the mean cycle time of the stem cell population (tCTS)b e -
ing modeled. Therefore,
εCTShCTS = ARCTS =
1
tCTS
. (12)2003:3 (2003) Connective Tissue Stem Cell Kinetics 177
Osteoblasts
2
4
6
12
18
36
36
ρap5 = 0.25
ρob5 = 0.75
ρap3 = 0.25
ρob3 = 0.75
Nob = Nshε2µ(ρob1ρob2ρob3 ···ρobx)
Nob = 1 × 1 × 26 × (1 × 1 × 0.75 × 1 × 0.75 × 1) = 64 × (0.5625) = 36
Figure 4. Competing diﬀerentiation options and events. The eﬀect of alternative commitment events on the number of mature
osteoblasts produced after the activation of one connective tissue stem cell is shown. In this example, the probability of retaining an
osteoblastic phenotype (ρob) was 1 after all mitotic events, with the exception of the third and ﬁfth symmetric mitosis. After the third
mitosis, 25% of the cells undergo apoptosis (ρob3 = 0.75). As a result, 16 fewer cells are produced. After the ﬁfth mitosis, 25% of the
cells commit to adipocytic diﬀerentiation (ρob5 = 0.75). Twelve adipocytes are the result. These events leave an overall probability of
osteoblastic diﬀerentiation (Pob) among the possible progeny of 0.5625 (0.75 × 0.75). The result is an approximately 44% reduction
in the total number of osteoblasts produced, from 64 to 36. Even if these progenitors continue to proliferate for many more cell
divisions before diﬀerentiating without further commitment to nonosteoblastic phenotypes, these two events related to the third and
ﬁfth mitosis eﬀectively limit the number of mature osteoblasts to only 56% of the theoretical maximum.
Therateofformationofnewosteoclasts
An analogous strategy can be applied to modeling the
steady state rate of formation of osteoclastic progenitors.
However, this requires a two-step approach. The precur-
sor cells that form the osteoclast are derived from the
HSC, but also transit through the compartment of cir-
culating monocytes before fusing to contribute nuclei to
mature multinucleated osteoclasts [103]. By analogy to
(10), the systemic rate of formation of mature monocytes
(dsNm/dt) can be described as
dsNm
dt
= sNHSC ARHSC 2µ
HSCPm, (13)
where
(i) sNHSC = the total number of HSC available for ac-
tivation, systemically,
(ii) ARHSC = the mean HSC activation rate,
(iii) µHSC = the eﬀective number of symmetric mitotic
cycles between the time of HSC activation and the
time of diﬀerentiation into mature monocytes,
(iv) Pm =thecumulativeprobabilitythattheprogenyof
the initial stem cell activation will retain monocyte
phenotype during the period of clonal expansion.
Similarly, the total number of systemic monocytes
(sNm) available to contribute to osteoclast formation by
cell fusion can be deﬁned by the product of the rate of
monocyte formation(dsNm/dt) andthe meanlife-spanof
am o n o c y t e( lm):
sNm =
dsNm
dt
lm. (14)
However, only a fraction of the monocytes that are
present systemically will contribute to osteoclast forma-
tion. To accommodate this variable, the probability that
any individual systemic monocyte will be activated to
contributetoosteoclastformationwithinadeﬁnedregion
of bone in a deﬁned unit of time can be assigned a value,
Pm→oc/dt. Furthermore, since multiple monocytes must
contribute to form a mature multinucleated osteoclast (a
mean of ∼ 8 cells)[103],afactorofn must be introduced,
equaltothemeannumberofmonocytescontributingtoa
mature osteoclast. Using these two additional factors, the
rate of formation of osteoclasts at steady state in a deﬁned
region of bone (dNoc/dt) can be expressed as
dNoc
dt
=

sNHSC ARHSC 2µ
HSCPmlmPm→oc/dt

n
. (15)
Combinedexpressionforbonetissueformation
andremodeling
Substituting factors for the rate of formation of os-
teoblasts and osteoclasts from (10)a n d( 15) into (8)p r o -
vides the following combined expression for the overall
balance of bone tissue formation within a given region of178 George F. Muschler et al 2003:3 (2003)
bone:
dT
dt
=

NCTSARCTS2µ
CTSPob

lob
dσob
dt
−

sNHSC ARHSC2µ
HSCPmlmPm→oc/dt

n
loc
dσoc
dt
.
(16)
Limitationsofthemodel
All models are inevitably based on simplifying as-
sumptions, which may not (and likely are not) univer-
sally true. Several of these assumptions require explo-
ration. Some assumptions require further reﬁnement as
discussed below.
One of the assumptions in the model, as presented
thus far, is that the stem cell activation and new osteoblast
formation both take place within the same region of in-
terest or observation. In contrast, the activation of the
HSC need not to occur within the region where the ma-
ture progeny are active. The validity of this assumption
for bone is dependent upon the relative size of the re-
gion of observation or sampling and the mean distance
between the site of connective tissue stem cell activation
and the site of mature osteoblast function. If this dis-
tance is on the order of 100–5000µm, then data avail-
able from conventional histomorphometry is likely to of-
fer wide enough sampling. However, there is a possibility
that this distance between the initiating stem cell niche
and the site of osteoblast function might be much larger
than the ﬁeld of sampling. For example, it has been sug-
gested that, like osteoclasts, some or all of the precursors
of mature osteoblasts may migrate for relatively long dis-
tances [104, 105, 106] or even circulate in blood as an os-
teoblastic transit cell population (OT) [107]. If this is the
case,it wouldbe necessarytoaccommodatea systemically
distributedosteoblastictransitcellpopulation.Takingthis
strategy, the expression for overall bone tissue formation
within a region of tissue could be written as
dT
dt
=

sNCTSARCTS2µ
CTSPotlotPot→ob/dt

lob
dσob
dt
−

sNHSC ARHSC2µ
HSCPmlmPm→oc/dt

n
loc
dσoc
dt
,
(17)
where
(i) Pot = the systemic cumulative probability that the
progeny of an activated connective tissue stem cell
would become an osteoblastic transit cell,
(ii) lot = the mean life-span of an osteoblastic transit
cell,
(iii) Pot→ob/dt = the mean probability that any individ-
ualosteoblastictransitcellwillbecomeanactiveos-
teoblast within the region of interest per unit time.
Another limitation in generalizing this strategy is the
fact that bone formation in diﬀerent locations and set-
tings may be derived from diﬀerent stem cell populations
having diﬀerent intrinsic capabilities and pathways. Tra-
becular bone remodeling, cortical haversian remodeling,
periostial new bone formation, myositis ossiﬁcans, ossi-
ﬁcation of a fracture callus, endochondral ossiﬁcation of
primary and secondary ossiﬁcation centers, ossiﬁcation
of an advancing growth plate, and ossiﬁcation within an
atherosclerostic plaque may each rely on the activation of
ad i ﬀerent pool or pools of connective tissue stem cells
having diﬀerent intrinsic attributes and extrinsic modu-
lating factors. Each stem cell pool may have intrinsically
diﬀerent activating signals, diﬀerent thresholds for acti-
vation, and diﬀerent activation rates. Each pool may give
rise to progeny that have intrinsically diﬀerent patterns of
proliferation or/and probabilities of diﬀerentiation along
an osteoblastic pathway. Furthermore, each pool of stem
cells will also be exposed to a diﬀerent set of extrinsic in-
ﬂuences (ie, biochemical, cytokine, matrix, and mechani-
cal environment) that is imposed by each tissue and loca-
tion or each stem cell niche. These diﬀering sets of intrin-
sicandextrinsicattributeswouldcombinetocreatediﬀer-
e n c e si nm e a na c t i v a t i o nf r e q u e n c y( h)a n de ﬃciency (ε),
cycle time (t), and activation rate (AR) for each stem cell
population and setting, as well as diﬀerences in number
of symmetrical mitoses in the clonal expansion phase (µ)
and the cumulative probability that an osteoblastic phe-
notypewouldbepreservedatthecompletionofclonalex-
pansion (Pob). Recognizing this limitation calls attention
to the fact that settings in which this strategy is applied
must be carefully deﬁned. Parameters determined in one
settingmaynotbegeneralizableinanother(eg,trabecular
versus cortical remodeling).
The model, as described above, has at least three other
major limitations. One limitation, and perhaps the great-
est, is that this model assumes that the pathway leading
to osteoblast development is associated with a single stem
cell activation event and a single stem cell population. In
fact, as discussed above, there is abundant evidence to
suggest that bone formation in trabecular bone and likely
other settings is associated with transit of cells through
more than one cell phenotype or transit cell compart-
ment. These transit steps likely involve a series of activa-
tion events. Recognizing this hierarchy of osteoblastic cell
development, the model is expanded below to accommo-
date multiple transit cell populations.
A second limitation is that this model does not con-
sider the fate of the osteoblast population after they con-
tribute to the population of active secretory osteoblasts.
Thetransitofthesecellsintothedownstreampopulations
of osteocytes and trabecular and osteonal lining cells and
ultimate cell death also has important implications in the
process of bone formation and skeletal health, and should
be included in a cell-based modeling approach.
Finally, the model does not address the issue of stem
cell renewal and expansion, which is clearly a critical
variable in the development, regeneration, and long-term
health of the connective tissue stem cell system.
The remainder of this paper will attempt to address
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downstream fate of osteoblasts, and stem cell renewal and
expansion.
THE TRANSIT CELL PARADIGM
The concept of transit cell populations has been ap-
plied to several models of stem cell kinetics, particularly
in the stem cell systems in dermal epithelium and in small
intestinal mucosa [98, 99, 108, 109, 110, 111, 112]. Tran-
sit populations have generally been deﬁned as cell pop-
ulations or stages of diﬀerentiation that are intermediate
between stem cells and mature cells. Transit cell popula-
tions can be deﬁned as compartments of either proliferat-
ing cells or nonproliferating cells. It is generally assumed
that the cells in each compartment are intrinsically diﬀer-
ent from the cells in another compartment, and the cells
in all transit compartments tend to progress irreversibly
toward the mature phenotype.
The concept of “proliferating transit populations” is
usedmostcommonly.Aproliferatingtransitpopulationis
generallyenvisionedtohavethecapacityforproliferation,
and some capacity for self-renewal or self-maintenance,
reducing the demand required for further activation of an
upstream stem cell compartment. However, if there is any
ongoing contribution from an upstream compartment,
stable regulation of cell numbers requires that the rate of
self-renewal in a proliferating transit population must be
less than 100% [111]. When a proliferating transit popu-
lation exists, it provides a means of cellular expansion. A
proliferating transit cell population is also inevitably as-
sociated with a physical migration of cells away from the
site of the upstream stem cell, since new cells must move
away or be pushed away from the site of cell division as
cell expansion occurs.
A highly simpliﬁed model involving three proliferat-
ing transit cell populations (T2, T3, and T4) in a con-
tiguous linear array feeding a population of mature cells
(M/T5) is illustrated in Figure 5. For simplicity, this is a
model composed entirelyof asymmetric celldivision. The
stem cell (S/T1) divides to renew itself and to produce a
T2 cell. The T2 cell divides as a transiently self-renewing
cell with a cycle time (t2) and life-span (l2)f o ran u m b e r
of cycles (µ2) giving rise to a number of T3 transit cells
(also equal to µ2) before its death. The T2 cell that dies is
then replaced by a new T2 cell generated by a subsequent
division of the upstream stem cell. The T3 population of
transit cells feeds the T4 population in the same way. For
each Tx compartment, µx = lx/tx. Ultimately, the T4 pop-
ulation gives rise to only cells that mature without divid-
ing (M/T5). These mature cells live out their functional
life-span (l5) and die. The table within Figure 5 illustrates
h yp o t h e t i c a lv a l u e sf o rtx, lx, µx, and the resulting number
o fc e l l si ne a c ht r a n s i tc o m p a r t m e n t( Nx) at steady state.
Figure 5 illustrates several features of the transit cell
paradigm.First,thechangeinanyoneparameterwillhave
secondary eﬀects on the number of cells in each compart-
ment (Nx), which is determined by the product of the rate
of cells entering that compartment (dNx/dt) and the life-
span of cells within that compartment (lx):
Nx =
dNx
dt
lx. (18)
It is also possible to deﬁne a velocity of cells leaving each
compartment in this linear model (Vx), where
Vx =
1
tx
= ARx . (19)
Figure 5 and the associated table also illustrate the
number of cell divisions that the stem cells in each com-
partment will be burdened with over the life of a hy-
pothetical individual (25,000 days, ∼ 68.5y e a r s ) .T h i s
demonstrates the principle value of proliferating transit
populations, which is the protection of the original stem
cell from the burden and genetic risk associated with di-
rect generation of each mature cell. In the case of the sys-
tem illustrated in Figure 5, in the absence of any transit
populations, the T1 stem cell would have needed to divide
25,000 times, rather than 25 times, to generate the same
number of mature cells over the life of the individual.
The transit cell model above is based on contiguous
unidimensional single-ﬁle cell to cell displacement. These
conditions are appropriate to models in the skin and in
the intestinal lining cell systems. A similar system might
also be relevant to modeling the progression of cell com-
partmentsintheactivegrowthplate,inarticularcartilage,
in the setting of periosteal new bone formation.
In the case of organizationally complex and heteroge-
neoustissues,suchasbone,acontiguousphysicalchainof
cells beginning at the stem cell is not applicable. Given the
requirementinboneforepisodicformationofnewsitesof
bone tissue formation in response to local tissue signals in
marrow or near the bone surface, it would appear that the
transit cell pools upstream of the osteoblast must include
one or more migratory transit populations that provide a
mechanism of physical migration and homing of progen-
itor cells from the (as yet uncharacterized) upstream stem
cell niche to a site near where they will activated to leave
the transit compartment and further diﬀerentiate.
Any system involving one or more transit populations
also requires some means of regulating of the total num-
ber of transit cells in each compartment. This regulation
could be mediated through modulation of the AR of the
upstream stem cell or rate of entry of upstream transit
cells. However, feedback regulation in this setting would
need to occur over signiﬁcant and potentially impractical
distances. As a result, regulation of the size of the local
transit population (ie, a function of the rate of entry, pro-
liferation, and residence time of cells within each com-
partment) is more likely to be mediated by the eﬀect of
localsignalsontheactivation/migrationAR,proliferation
kinetics (µ), diﬀerentiation (P), or life-span (lx).
Transit populations can also serve to distribute the
progeny of stem cells beyond the limited domain of the
upstream stem cell niche. This may occur by migration of180 George F. Muschler et al 2003:3 (2003)
T1
T2
T3
T4
T5
tx lx µx Nx Vx
1000 days 25,000 days 25 1 .001
100 days 1000 days 10 1 .01
20 days 200 days 10 2 .1
1 day 10 days 10 1 1
∞ 10 days 0 10 10
tx = cycle time
lx = life-span
µx = total mitoses in lifetime = lx/tx
Nx = number of cells = Nx−1lx/tx−1
Vx = velocity of cells leaving this compartment (cells/day) (Nx/tx)
Figure 5. Conceptual model of transit cell ampliﬁcation. This schematic diagram and associated table illustrate several central con-
cepts in the proliferating transit cell paradigm. A stem cell (T1) and three proliferating transit cell populations (T2, T3, and T4) are
modeled at steady state in a contiguous linear array supporting a population of mature cells (M/T5). All cell division is modeled as
asymmetric events associated with renewal of the founding cell. The table illustrates hypothetical values for the cycle time (tx), life-
span for cells in each compartment (lx), the eﬀective mean number of cell divisions in each compartment (µx), the resulting number
of cells resident in each transit compartment (Nx), and a velocity or rate at which cells leave each compartment (Vx). In this model,
the originating stem cell survives throughout the life of the individual (l1 = 25,000 days ∼ 68 years), cycling as a slow rate of one cell
division every 1000 days (t1 = 1000 days). During the life of the stem cell, it divides a total of 25 times (µ1 = 25). The velocity of cells
leaving the stem cell compartment and entering the T2 compartment is 1 cell per 1000 days, or V1 = 0.001 cells/day. Cells in the T2
compartment function similarly to feed the T3 compartment, and so on. Cells in downstream populations (T2, T3, and T4) divide
more rapidly than cells in upstream compartments. In contrast to the originating stem cells, the cells in downstream compartments
also have limited self-renewal capacity, resulting in decreasing functional life-span for cells in each compartment. Note that, in the
absence of any transit populations, the upstream stem cell would need to divide 25,000 times to generate the same number of mature
cells over the life of the individual.
transitcellsthroughtissueorbytransportwithinsystemic
circulation, as is the case with the transit monocyte popu-
lation that contributes to osteoclast formation. A broadly
distributed migratory transit population, having the po-
tential for proliferation, also provides advantages in the
setting of tissue injury and repair. Locally resident tran-
sit cells are better positioned to respond to changes in lo-
cal tissue conditions and signaling events, and potentially
avoid the inevitable delay that would result if tissue repair
was to require the activation, proliferation, and migration
of cells from a remote upstream stem cell niche.
Transitpopulationsupstreamofthe
osteoclastcompartment
A diagram of transit cell compartments upstream
of the osteoclast is relatively simple to illustrate con-
ceptually. (See Figure 6.) The diagram begins with the
small population of adult pluripotent hematopoietic stem
cells that have long-term repopulating potential (HSC-
LT) [113, 114]. These are activated to divide and their
nonstem cell progeny undergo symmetric clonal expan-
sion, passing through a series of downstream “prolifer-
ating transit populations.” These downstream transit cell
pools include a small population of cells that have lim-
ited self-renewal capacity, resulting in short-term repop-
ulating activity (HSC-ST) but still give rise to multipo-
tent progeny. Further downstream are a population of
common myeloid progenitors followed by granulocyte
macrophage precursors (CFU-GM) and ﬁnally commit-
ted macrophage forming progenitors (CFU-M).
Cells in the CFU-M compartment in marrow exit
from the marrow space and enter into a “nonproliferating
transit population,” as circulating monocytes, with some
probability (PM). Monocytes are then distributed system-
ically in circulation, making them accessible to local acti-
vation signals for a period of time (lM). These local sig-
nals can result in their subsequent activation to move into
other cell compartments, including tissue monocytes and
macrophages. The third transit compartment in the os-
teoclast lineage is the tissue monocyte that has left circu-
lation to reside in the bone marrow or osteonal compart-
ment of bone. The fourth and ﬁnal transit compartment
is the osteoclast compartment, where monocyte-derived
nuclei fuse to transiently contribute to the osteoclast pop-
ulation.Theosteoclastpopulationpersiststhroughoutthe2003:3 (2003) Connective Tissue Stem Cell Kinetics 181
NHSC-LT
NHSC-ST
NCMP
NGMP
NM
NBTM
NOC
dNM/dt
CLP
MEP
Granulocytes
lM
Figure 6. Transit cell populations in osteoclast formation. The
conceptual hierarchy of transit cell populations upstream of the
osteoclast is illustrated. Triangles indicate phases of clonal ex-
pansion arising from proliferating transit populations. Black ar-
rows indicate transit events in which cells move from one com-
partment to another associated with changes in their intrinsic
biological properties. Grey arrows indicate departure of cells
from the upstream compartment to other cell compartments.
Green boxes illustrate the conceptual size of each cell popula-
tion,wherethewidthoftheboxrepresentstherateatwhichcells
are added to or leave each compartment at steady state, and the
height of each box represents the mean life-span or residence
time of cells within each compartment. (Abbreviations: HSC-
LT, long-term repopulating hematopoietic stem cell; HSC-ST,
short-term repopulating hematopoietic stem cell; CMP, com-
mon myeloid progenitor; CLP, common lymphoid progenitor;
MEP, megakaryocyte erythroid progenitor; GMP, myelomono-
cytic progenitor; M, monocyte; BMT, bone tissue monocyte;
OC, osteoclast nuclei [114].)
life of the cutting cone of a BMU. However, this pop-
ulation is continually fed by the addition of new nuclei
through new fusion events, balancing the simultaneous
turnover of other nuclei. The transit time for nuclei in the
osteoclast compartment has been estimated to be approx-
imately 12.5 days [115].
Each of these transit compartments is associated with
a n dd e ﬁ n e db ya no v e r a l lA R ,m e a nn u m b e ro fe ﬀec-
tive mitoses (µ), mean life-span (l), and probability of
transit to the downstream population (P). The process
of monocytes nuclei contributing as a transit population
to osteoclast generation is rather unique. In terms of ab-
solute cell number, transition from monocyte to osteo-
clast represents a reverse ampliﬁcation event, requiring
several monocytes (∼ eight) to make one osteoclast (ie,
µ ∼− 3).
Using this model concept, access to quantitative infor-
mation about the number of cells (nuclei) in each com-
partmentandthemeanlife-spanofcellswithineachcom-
partment can be used to gain signiﬁcant insight into the
possible range of kinetic parameters governing the transit
processes leading to osteoclast development.
Transitpopulationsdownstreamofthe
osteoblastcompartment
Using the transit cell paradigm described above, it is
also possible to begin to build a model system of transit
cell compartments that contribute upstream to osteoblast
formation,andtomodelthedownstreamtransitcellcom-
partments that contribute to the removal of osteoblasts.
Much more is known about the downstream transit
compartments, as illustrated in Figure 7, than about com-
partments that are upstream of the osteoblast. Removal
of osteoblasts from a region (ie, the transit of cells out
of the osteoblast compartment) occurs through three pri-
mary pathways or transit events: formation of an osteo-
cyte, formation of a lining cell, and cell death via apopto-
sis. These variables are absent from the model developed
above, because the model was based on the variables in-
ﬂuencing the rate of bone tissue formation and removal,
and the contribution of osteoblasts to bone matrix vol-
umeendswhentheytransitoutoftheosteoblastcompart-
ment. However, the transit of osteoblasts into the down-
stream populations of osteocytes and lining cells, while
not a determinant of the rate at which new bone tissue is
formed, is a critical variable determining the density and
distribution of osteocytes and lining cells, and therefore
the histologic features, biologic environment, and long-
term health of the newly formed bone tissue. The distri-
bution of these cells in bone tissue is likely to have signiﬁ-
cant eﬀects on the function and maintenance of the newly
formed bone and on the initiation and propagation of fu-
ture cycles of bone resorption and bone formation in that
tissue volume.
The mean probability that any given osteoblast will
follow one of these pathways can be represented as
ρo +ρl +ρap = 1, (20)
where
(i) ρo = the probability of forming an osteocyte,
(ii) ρl = the probability of forming a lining cell,
(iii) ρap = the probability of apoptosis.
Based on this concept, and substituting the expression
fortherate of osteoblastformation (Nob/dt) into(10),the182 George F. Muschler et al 2003:3 (2003)
dNOb/dt
NOb
NO NL
Apoptosis
lOb ∼ 0.1years
ρo = .20
ρA = .75
ρ1 = .05
lO ∼ lL ∼ 15–25years
Figure7.Transitcellpopulationsdownstreamoftheosteoblast.Thethreediﬀerentiationpathwaysavailabletoosteoblastsandthetwo
transit populations downstream of the osteoblast are illustrated, using the same illustration strategy described in Figure 6. Probability
values that would be common in cortical osteonal bone remodeling are illustrated.
rate of formation of new osteocytes (No/dt)c a nb ee x -
pressed as
No
dt
=
Nob
dt
ρo = NCTSARCTS2µ
CTSPobρo. (21)
Assuming steady state conditions, then the total num-
ber of osteocytes in a region (No) will expressed as
No =
Nob
dt
ρolo = NCTSARCTS2µ
CTSPobρolo, (22)
where, lo = the mean life-span of an osteocyte.
Similarly, at steady state, the relative number of osteo-
cytes and osteoblasts in a given region of bone can be ex-
pressed as
No
Nob
= lo
ρo
lob
. (23)
Based on rough estimates of these values (ρo ∼ 0.2,
lo ∼ 20 years, lob ∼ 0.1y e a r s )[ 85, 86], the mean ratio
of osteocytes to active osteoblasts should be in the range
of 40 to 1. However, this is expected to vary signiﬁcantly
between sites. The diﬀerence in remodeling rate between
cortical and cancellous bone results in a generally longer
life-span of osteocytes in cortical bone than in trabecular
bone. Similarly, ρo will change signiﬁcantly with the ge-
ometry of the site of bone formation, as discussed below.
The rate of formation of new osteoblasts (Nob/dt)c a n
also be investigated beginning with data available from
histomorphometric measurements. At steady state, this
rate will be equal to the rate at which osteoblasts transit
out of the osteoblast compartment (rNob/dt). The rate of
removal will be related to the total number of osteoblasts
in the region of interest (Nob) and life-span of the os-
teoblast, based upon the relationship derived from (4):
rNob
dt
=
Nob
dt
=
Nob
lob
=
NCTSARCTS2µ
CTSPobρolo
lob
.
(24)
Since the rate of removal of osteoblasts (rNob/dt)c a n
also be expressed as a sum of the rate of the three path-
ways, or
rNob
dt
=
No
dt
+
Nl
dt
+
Nap
dt
, (25)
where,
No/dt = the rate of formation of new osteocytes
Nl/dt = the rate of formation of new lining cells
Nap/dt = the rate of osteoblast loss due to apopto-
sis,
the relative velocity of the three rates is determined by
the relative probability that a mature osteoblast will fol-
low each of the pathways (ρo, ρl,a n dρap).
Finally, the density of osteocytes within the newly
formed bone matrix (Do) will be determined by the rate
of formation of new osteocytes (No/dt), the number of
active osteoblasts (Nob), and the rate of formation of new
bone matrix per osteoblast (dσob/dt), according to the re-
lationship
Do =
No/dt
Nob
·
dσob
dt
. (26)2003:3 (2003) Connective Tissue Stem Cell Kinetics 183
Substituting terms for No/dt and Nob from (21)a n d( 4),
respectively, provides that
Do =

NCTSARCTS2µ
CTSPob

×
ρo 
NCTSARCTS2µ
CTSPob

×lob
dσob
dt
or Do =
ρo
lob
dσob
dt
.
(27)
It is interesting to note that, osteocyte (lacunar) den-
sity has been reported to be higher in females than in
males [116], and higher in osteoporosis subjects than in
age-matched normal subjects [94]. These ﬁndings would
suggest that the pathomechanics of osteoporosis may be
associatedwithadecreasedrateofmatrixsynthesisperos-
teoblast (dσob/dt), a decrease in osteoblast life-span (lob),
and/or an increase in the probability of osteocyte forma-
tion (ρo).
It is also interesting to note that the anatomic site or
geometry of the BMU will have an profound inﬂuence
over the likely fate of an osteoblast with respect to the
probability of apoptosis or diﬀerentiation as a lining cell
[79]. Figures 8a through 8c and data presented in Table 1
illustrate the predicted range of variation in the probabil-
ity factors regulating the fate of osteoblasts with geometry
of the site (ie, the contour and thickness of the new bone
formed) and with osteocyte density (eg, cortical versus
trabecular cancellous bone). Increasing matrix thickness
and increased osteocyte density are associated with an in-
creased probability (ρo)o fo s t e o c y t ef o r m a t i o n ,a n dad e -
crease in the allowable probability of apoptosis (ρA). Sim-
ilarly,thetransitionfromconcavesurfaces(suchasthein-
terior of anosteon in Figure 8a) to formation of new bone
on a ﬂat surface (such as a periosteal surface or trabecu-
lar plate as shown in Figure 8b) or to formation of new
bone on a convex surface (such as the cylindrical section
of a trabecular strut illustrated in Figure 8c) is associated
with increasing demands and probability of transit to lin-
ing cell and osteocyte population, and a decreasing allow-
able range of apoptosis. These changes are also associated
with an increase in the mean volume of new bone synthe-
sis required per starting osteoblast (σob). The need for os-
teoblast retention as osteocytes and lining cells eﬀectively
limits the maximal thickness of new bone matrix produc-
tion with each remodeling cycle, particularly on convex
surfaces.
Transitpopulationsupstreamofthe
osteoblastcompartment
Direct objective information upon which to build a
conceptual model for transit cell compartments upstream
oftheosteoblastismuchmorediﬃcult.Regardlessofthis,
there is a signiﬁcant volume of data and observation that
can be assembled in an attempt to strategically dissect
questions related to the likely size, hierarchy, and kinetics
of transit populations upstream of the osteoblast.
(a) (b) (c)
Figure 8. The eﬀe c to fs u r f a c eg e o m e t r yo nt h ef a t eo f1 2 8o s -
teoblasts.Acell-basedmodelisshownrepresentingboneforma-
tiononthreediﬀerentsurfacegeometries:(a)aconcavesegment
of a 200µm diameter osteon in cortical bone, (b) a ﬂat surface
in cortical or cancellous bone, and (c) the convex surface of a
100µm diameter trabecula in cancellous bone. In each case, a
set of 128 osteoblasts is shown at t = 0a s∼ 12.5µ cuboidal
cells covering an appropriate segment of the bone surface. Be-
low, the same surface and the new bone formed by this set of
128 osteoblasts are shown. In each case, some fraction of cells
must become embedded in the matrix as osteocytes to maintain
an appropriate osteocyte density and some osteoblasts must be
retained as lining cells covering the remaining surface. Cells that
are not required as osteocytes or lining cells are presumed to be
lost through apoptosis. The probability of osteoblast transit into
the osteocyte or lining cell population, and the probability of
apoptosis are dependent on surface geometry, the density of os-
teocytes in the matrix, and the thickness of the new bone that is
formed at the site.
As discussed above, Bianco et al [72, 73]h a v ep r e -
sented histologic observations to support the concept that
osteoblasts in bone may be derived from a population
of ﬁbroblastic cells in bone marrow known as Westin-
Bainton cells. Other evidence indicates that cells derived
from the perivascular compartment (vascular pericytes)
have the capacity to contribute to the osteoblast compart-
ment [69, 70]. There is also recent evidence suggests that
osteogenic cells may also transit through peripheral blood
[107, 117]. As a result, it is necessary for any model of
osteogenic transit populations to include not only an up-
stream stem cell niche, but also possible transit compart-
ments of circulating cells, vascular pericytes, and Westin-
Bainton cells.
Detailed histologic analysis of BMUs in cortical bone
and radioactive labeling studies has also suggested the
presence of another small compartment of proliferating
cells that is located very close to the junction of the osteo-
clastsinthecuttingconeoftheBMUandtheregionwhere
all new osteoblasts are incorporated. Radionucleotide la-
beling is seen within this population of cells early after
injection, suggesting a high proliferation rate. Further-
more, by 1–1.5 days after labeling, radiolabel remains ev-
ident in the type I population and is also seen in the new184 George F. Muschler et al 2003:3 (2003)
Table 1. The eﬀect of osteocyte density and surface geometry on osteoblast fate and function. This table provides a quantitative
assessment of the end result in each geometric conﬁguration illustrated in Figures 8a, 8b,a n d8c. Each geometry calculations are
based on formation of 40µmo r6 0µm thick volume new bone. The table illustrates the fate of the initial set of 128 osteoblasts,
identifying the number of osteocytes (No) and lining cells (NL) that are required and the probability of an initial osteoblast form an
osteocyte (ρo), a lining cell (ρl), or to undergo apoptisis (ρA). Calculations for cortical and trabecular cancellous bone diﬀer based on
published values for osteocyte density in cortical and trabecular bone. Note that the required probability for osteocyte formation (ρo)
increases dramatically in these examples from 0.13 to 0.69 as the surface geometry changes from concave to convex, as the osteocyte
density changes from cortical to cancellous bone, and as the thickness of new bone increases.
Nob
No
NL
NA
Po
PL
PA
Do (osteocytes/µm3)
σob (µm3)
Total matrix (µm3)
Matrix thickness (µm)
128
17
5
106
0.13
0.04
0.83
0.000026
5152
659400
40
Corticoid
128
23
4
101
0.18
0.03
0.79
0.000026
6991
894900
60
Corticoid
128
21
8
99
0.16
0.06
0.78
0.000026
6,250
800,000
40
Corticoid
128
31
8
89
0.24
0.06
0.70
0.000026
9,375
1,200,000
60
Corticoid
128
38
8
82
0.30
0.06
0.64
0.000047
6,250
800,000
40
Cancellous
128
56
8
64
0.44
0.06
0.50
0.000047
9,375
1,200,000
60
Cancellous
128
51
14
63
0.40
0.11
0.49
0.000047
8,517
1,090,000
40
Cancellous
128
88
17
23
0.69
0.13
0.18
0.000047
8,517
1,090,000
60
Cancellous
Osteon Flat Convex
Table 2. Maximum matrix thickness of new bone formation on a concave, ﬂat, or convex surface. This table illustrates the maximum
theoretical thickness of new bone formation for the 128 cells illustrated in each geometric conﬁguration shown in Figures 8a, 8b,a n d
8c. For ﬂat and convex surfaces, the limit occurs when osteoblasts become osteocytes and lining cells and no osteoblast undergoes
apoptosis (ρA = 0). In contrast, in the concave conﬁguration of an osteon, the thickness is limited by the maximum diameter of a
cylinder that can be occupied by a single row of 128 osteoblasts (∼ 250µm). In this case, approximately half of the initial osteoblasts
must still undergo apoptosis if the observed osteocyte density is to be maintained at or near the normal osteocyte density in cortical
bone.
Nob
No
NL
NA
Po
PL
PA
Do (osteocytes/µm3)
σob (µm3)
Total matrix (µm3)
Matrix thickness (µm)
128
61
1.5
64
0.48
0.01
0.51
0.000026
18,408
2,356,192
250
Corticoid
128
120
8
0
0.94
0.06
0.00
0.000026
36,058
4,615,385
231
Corticoid
128
120
8
0
0.94
0.06
0.00
0.000047
19,947
2,553,191
128
Cancellous
128
109
19
0
0.85
0.15
0.00
0.000047
18,099
2,316,692
70
Cancellous
Osteon Flat Convex2003:3 (2003) Connective Tissue Stem Cell Kinetics 185
dNOb/dt
1Ob NOb
NPre-Ob
NWB
NP
NC
NS
?
?
?
?
Adipocytes
Figure 9. Transit cell populations upstream of osteoblasts. The
putative transit cell populations that are upstream of the os-
teoblastareshown,usingthesameillustrationstrategydescribed
in Figures 6 and 7. The upstream originating stem cell, the peri-
cyte, and the pre-osteoblast (type I osteoblast) are all presumed
to be proliferating transit populations. Precise features of this
diagram (the magnitude of expansion, the life-span, the rate
of transit, and even pathways of transit between these potential
populations) must be considered highly speculative, though it is
consistent with available data and prevailing theory. Regardless
of this speculation, it is useful to compare this diagram to that
illustrating the events that occur downstream of the osteoblast
shown in Figure 7. This comparison illustrates the very small
rate of cell division and small rate of transit that must be ex-
pected in transit populations upstream of the osteoblast, rela-
tive to downstream events. Similarly, it also illustrates that one
or more of these upstream populations (eg, the Westin-Bainton
cell) might be present in comparable numbers to the active os-
teoblast population, if the life-span of cells in these transit com-
partments signiﬁcantly greater that was the life-span of the se-
cretory osteoblast. (Abbreviations: S, upstream stem cell; C, cir-
culating stem cell; P, vascular pericytes; WB, Westen-Bainton
Cells; Pre-Ob, Pre-osteoblast (Type I osteoblast); Ob, mature se-
cretory osteoblast.)
osteoblastic cells that are added to the advancing front
of osteoblasts. This unique population of cells, about 8
cells per BMU, has been referred to as type I osteoblasts
[102, 118]. Based on these observations, we interpret this
population of cells to represent a small proliferating tran-
sit population that is immediately upstream of the secre-
toryosteoblastwhichhassomeself-renewalcapacity,sim-
ilar to the transit populations illustrated in Figure 5.
Many possible models could be proposed to linking
these compartments into a hierarchy. However, in the ab-
sence of compelling data to the contrary, the simplest
possible model involving all of these compartments is a
model of linear progression of cells through these com-
partments in an order that is based on physical proxim-
ity to the bone forming surface analogous to the previous
model for osteoclast formation, as illustrated in Figure 9.
In this model, osteogenic cells may be envisioned to tran-
sit through a stem cell and progenitor cell system with up
to ﬁve compartments upstream of the mature secretory
osteoblast. This model begins with a true initiating stem
cell population (NS or T1), followed by a circulating tran-
sit cells (NC or T2), the pericyte compartment (NP or T3),
theWestin-Baintoncompartment(NWB orT4),TypeIos-
teoblasts (NobI or T5), and secretory osteoblasts (Nob or
T6).
With the exception of the type I osteoblast compart-
ment, there is no objective data to demonstrate the tran-
sit of cells between these compartments, nor prolifera-
tionwithinanyonecompartment,includingtherelatively
abundant population of Westin-Bainton cells. As a re-
sult, the transit of cells between these compartments and
the stem cell kinetics associated with these compartments
(proliferating or non-proliferating transit) under normal
remodelingconditionsisentirelyspeculative.Itseemsrea-
sonable to assume with some conﬁdence that the origi-
nating stem cell compartment represents a proliferating
transit population, though the kinetics of this compart-
ment is entirely unknown. Similarly, given the capacity
o fp e r i c y t e st ob ec u l t u r e di nv i t r ot op r o d u c eap r o l i f -
erating population of osteogenic cells, it seems reason-
able to expect that the pericyte compartment also repre-
sents a proliferating transit population, as illustrated in
Figure 9.AlsorepresentedinFigure 9istheseeminglyrea-
sonable assumption that the life-span of a pericyte and of
a Westin-Bainton cell is quite long in comparison to the
life-span in the compartments containing the circulating
osteoblastic progenitor, type I osteoblast, or osteoblasts
themselves, though the actual life-span of cells in these
compartments is not known. The number of symmetric
mitoses in the stem cell compartment or pericyte com-
partment is also entirely speculative. The same is true for
the probability that the cells leaving each of these com-
partmentswilltransit tothe next, thoughforgraphicpur-
poses Figure 9 arbitrarily illustrates a probability (P)o f
transit to the next compartment of ∼ 0.5.
Despite these limitations, this organizational hierar-
chy provides a starting point from which to explore and
test assumptions regarding the relative size of these com-
partments, the presence or absence of transit events be-
tween these compartments, and the rate and kinetics that
may be associated with these events in order to support
bone remodeling and/or in settings of injury or repair.
This is illustrated below.
In accord with the previous discussion, for each com-
partment, the rate at which cells are added to a compart-
ment(dNx/dt)isalsoequaltotherateatwhichcellsmove
from the upstream compartment to the next, and can be
represented as
dNx
dt
= Nx−1ARx−12µ
x−1Px, (28)
where
(i) Nx−1 =numberofcellsintheupstream(x−1)pop-
ulation,
(ii) ARx−1 = mean activation rate of cells in the up-
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(iii) µx−1 = mean number of symmetric mitoses in the
upstream (x −1) population,
(iv) Px = the probability of cells generated in the up-
stream (x − 1) population to become a transit cell
in the x population.
Based on this relationship, with the exception of the
initiating stem cell population (T1), the total number of
c e l l si ne a c hc o m p a r t m e n t( Nx)c a nb er e p r e s e n t e da s
Nx =
dNx
dt
lx = Nx−1ARx−12µ
x−1Pxlx, (29)
where lx = mean life-span of a cell in the x population.
Note. If the upstream compartment is composed of
only nonproliferating transit cells (ie, µ = 0), the term AR
is equal to the rate at which cells in this compartment are
activated to leave their current state and transit to another
compartment.
Based upon the relationship described in (29), the ra-
tio of the number of cells observed in one compartment
and the number of cells observed in an adjacent compart-
ment becomes a tool in the assessment of the kinetics be-
tween two adjacent compartments, since
Nx−1
Nx
=
1

ARx−12µ
x−1Pxlx
. (30)
The logical starting point to begin to evaluate the utility
of this theoretical relationship is in an exploration of the
kinetic interface between the T5 population of type I os-
teoblasts and the T6 compartment of active secretory os-
teoblasts, where at least some objective data exists. This
data suggests that the ratio of type I osteoblasts to se-
cretory osteoblasts is approximately 1 : 125 (∼ 8t y p eI
osteoblasts to 2000 secretory osteoblasts in a fully active
cutting cone) [102, 118] and that this population prolifer-
ates relatively rapidly, allowing cells to exit this compart-
mentwithinabout24–36hours.Beyondthisinformation,
the remainder of a ﬁrst-order analysis must be based on a
set of assumptions. One set of possible parameters that is
useful for a ﬁrst-order exploration includes the following
three assumptions: (1) all type I osteoblasts become os-
teoblasts (PobI = 1), (2) the activation rate of the cells in
the type I compartment is approximately one cell division
per day (ARobI = 1, ie, a cycle time of 24 hours), and (3)
the total number of asymmetric mitoses per cell during
residence within the type I osteoblast compartment is in
the range of 13 (lobI ∼ 13 days).
If these assumptions are correct, then two other pa-
rameters follow. First, based on substitution into (30),
the eﬀective number of symmetric mitotic events (µobI)
predicted among the progeny of an activated type I os-
teoblast would slightly be greater than 3, resulting in ap-
proximately 10 new osteoblasts for each activation event.
Second, the rate at which new type I osteoblasts would
need to be added from the upstream compartment would
be approximately 0.6 cells per day (dNobI/dt = NobI/lobI =
8/13).
While these assumptions and the calculated kinetic
parametersresultingfromthisexampleareinternallycon-
sistent and within the range of predicted biological feasi-
bility, this example must not be over interpreted. Current
markers for stem cell and progenitor cell populations and
histomorphometric methods for counting cells and mea-
suring proliferation rates in vivo, have not yet provided
the means of reliably testing the validity and utility of this
approach. Without these data, the model is primarily use-
ful as a conceptual tool for interpretation of increasingly
rich and quantitative histologic and histomorphometric
data.
Applicationofcell-basedmodelingtotheclinical
andexperimentalsettings
Whilethequantitativedatatosupportthefullapplica-
tion of a cell-based modeling strategy is not yet available,
an increasing number of publications are providing data
that will allow these kinds of analysis. For example, in the
setting of estrogen deﬁciency, there is recent evidence of
a decreased life-span among both osteoblasts and osteo-
cytes [119]. Systemic exposure to corticosteroids also has
these eﬀects [120]. These ﬁndings are consistent with the
observedcontractionofbothofthesetransitcellcompart-
ments in both settings.
Cell-based modeling may also be useful in interpre-
tation of the apparent accumulation of Westin-Bainton-
like alkaline phosphatase-positive cells within the areas of
intramedullary ﬁbrosis that is observed in hyperparathy-
roidism [121]. In this context, an increase in size of a
Westin-Bainton-like compartment would be attributed to
increasedactivation(ARP)orproliferation(µP)intheup-
stream compartment (eg, pericytes), an increased proba-
bility that cells from the upstream compartment will en-
ter the WB compartment (PWB), or an increase in life-
span of cells within the WB compartment (lWB). An in-
crease in life-span could in turn be mediated by a de-
crease in the rate with which cells in the WB popula-
tion are activated to transit downstream compartments
(ARWB). The accumulation of intramedullary ﬁbrous tis-
sue in the setting of ﬁbrous dysplasia, a condition re-
sulting from constitutive activation of a Gα S-protein,
similar to the pathway activated by tonic PTH stimu-
lation, may also be interpreted in this way [106, 122,
123].
Cell-basedmodelingmayalsobeinstructiveinthede-
sign and selection of experimental strategies. For exam-
ple, the model predicts that the magnitude or velocity
of transit events into the type I osteoblast pool does not
need to be very large in order to support ongoing bone
remodeling activity. This would imply a low basal acti-
vation rate in the upstream compartment. Activation in
the Westin-Bainton population (ARWB) could be partic-
ularly rare in light of the relative abundance of Westin-
Bainton cells in bone marrow. As a result, observation
of these transit events during normal bone remodeling
would be highly unlikely. The setting of intramedullary2003:3 (2003) Connective Tissue Stem Cell Kinetics 187
α 2αµ
Figure 10. Three options for stem cell division. Three possible
outcomes of stem cell activation and cell division are illustrated:
an “α” division represents the classic asymmetric cell division
with renewal of the mother cell and generation of a daughter
that enters a downstream transit population. A “2α”c e l ld i v i -
sion generates two identical stem cells, increasing the number
of total stem cells by one. Finally, a “µ” division generates two
cells that enter a downstream transit population, depleting the
number of stem cells by one. The balance between “2α”a n d“ µ”
events determines whether a given stem cell pool will increase or
decrease in number.
trauma or fracture healing might be expected to be very
diﬀerent, however, since the Westin-Bainton population
(and/or the pericyte population) would appear to be the
osteogenic transit compartments that are most eﬀectively
positioned to respond in the rapid regional mobilization
of the bone healing response that is required in these set-
tings.
Finally, as it is further developed, cell-based modeling
will oﬀer many new capabilities for interpretation and in-
vestigation of in vivo phenomenon in the setting of em-
bryonic development, tissue remodeling, disease states,
responses to targeted drug and cell therapies, the tissue
level eﬀects of targeted mutations and knockouts. For ex-
ample, if a pharmacologic agent, disease, mutation, or
knockout was found to be associated with a signiﬁcant in-
crease in the number and prevalence of type I osteoblasts,
then targeted assessment of the ARobI, lobI, µobI, Pob,o r
lob should reveal the underlying kinetic process that is af-
fected and responsible for this change.
Ultimately, the utility and validity of cell-based mod-
els must be tested against experimental data involving
direct measurement of the number of cells in the rele-
vant compartment and their associated kinetic parame-
ters. This will require signiﬁcant improvement in the cell
speciﬁc markers and methods that are currently available.
STEM CELL AND TRANSIT CELL SELF-RENEWAL
AND SELF-EXPANSION
Cell-basedmodelingalsorequiresstrategieswhichde-
scribe the origin, expansion, and maintenance of the stem
cell and transit cell populations throughout the life of an
individual,viathebiologicallyessentialprocessreferredto
commonly as self-renewal. An extensive literature is avail-
able on this subject [99, 111], which cannot be reviewed
here. However, some exploration of these concepts is ap-
propriate to the development of the current model.
When a stem cell is activated, at any stage of devel-
opment, there are conceptually three possible outcomes,
as illustrated in Figure 10. The classic mechanism for self-
renewal is “asymmetric division” producing one daughter
cell that is identical to the mother cell and one daugh-
ter cell that is intrinsically diﬀerent than the mother cell
and goes on to proliferate and mature. For the purpose of
this discussion, and to remain consistent with a previous
publication, we referred to this as an “α” division [59].
This mechanism by itself would be suﬃcient to maintain
the stem cell population in adults. However, at least two
other options are possible. Two stem cells that are iden-
tical to the mother could also be produced (a “2α”c e l l
division in Figure 10). Alternatively, two daughters could
resultwhichare both diﬀerentthanthemothercell,which
we have referred to as a “µ” division. As a result, in any
population of stem cells, any individual activation event
would have some probability of each of these three path-
ways (pα, p2α,a n dpµ,r e s p e c t i v e l y ) ,w h e r e
pα + p2α + pµ = 1. (31)
Each of these pathways must be possible. In adult life,
whenmaintenanceofstemcellpopulationswouldseemto
be the goal, one might expect that the α division would be
strongly favored, and that the frequency of the other two
pathways would be small (pα   p2α,p µ). However, this
situationisnotrequiredforstemcellmaintenance.Astem
cell population can be maintained even if the probability
of α division is low, provided that the probability of 2α
and µ divisions were equal over time (p2α = pµ).
The mechanism by which each stem cell population
maintains functional self-renewal is therefore uncertain,
and may vary greatly depending upon the population.
What is deﬁnite, however, is that the probabilities of these
diﬀerent stem cell division pathways shift signiﬁcantly
during growth and development. Embryonic growth and
development must be accompanied by a signiﬁcant ex-
pansion in the number of stem cells. Therefore, during
development, stem cell activation must be associated with
ah i g hp r o b a b i l i t yo fa2 α cell division over µ (p2α >
pµ), and possibly of α divisions as well. Similarly, there
are settings in which stem cell populations become de-
pleted or even extinguished. Examples include the loss of
hematopoiesisintheliverandperipheralskeleton,andthe
apparent loss of embryonic stem cells and hemangioblasts
during development. In settings of stem cell depletion or
extinction, “µ” division of stem cells must occur with in-
creased probability (pµ >p 2α), unless one hypothesizes
direct stem cell death as a mechanism for stem cell reduc-
tion.
It is possible to speculate with some justiﬁcation that
self-renewal, in the form of either α or 2α divisions, in-
volves activation of genes linked to cell cycle regulation
[124, 125, 126]. However, our ability to observe, detect,
or distinguish between these events and mechanisms in
activated stem cells is limited to very few settings [127].
Recognizing current limitations in dissecting these
events at the level of individual cells within a population,
we suggested in our previous publication [59] the concept
of a global index variable (α) to characterize the status of
self-renewal in a population, where α is equal to the mean188 George F. Muschler et al 2003:3 (2003)
number of stem cells remaining after each stem cell acti-
vation. In the context of the previous discussion, α can be
represented as
α = pα +2p2α (32)
and α will have a range of possible values from 0 to 2.
Usingthisindex,therateatwhichstemcellsareadded
or removed from a stem cell population by variation in
self-renewal probability (dNs→s/dt)c a nb er e p r e s e n t e da s
dNs→s
dt
=

αs − 1

ARs, (33)
where
(i) ARs = the activation rate for the stem cell popula-
tion in question,
(ii) αs = the self-renewal index for the stem cell popu-
lation.
This same strategy can be used to describe the rate at
which new cells are added by a self-renewal mechanism
within any downstream proliferating transit cell popula-
tion. However, in the case of a downstream transit com-
partment, the total rate at which new cells are added
(dNx
TOTAL/dt) is equal to the sum of the cells added by
self-renewalwithinthatcompartment(dNx→x/dt)andthe
rate at which cells are added by progression of cells from
the compartment that is immediately upstream (dNx/dt),
from (28) above. Therefore,
dNx
TOTAL
dt
=
dNx→x
dt
+
dNx
dt
=

αx − 1

ARx +
dNx
dt
.
(34)
As a condition of steady state, it is necessary that
dNx
TOTAL/dt equal to zero. Therefore, it follows that:
αx = 1 −

dNx/dt
ARx

. (35)
Thisrelationshipillustratesseveralinterestingfeatures
of the concept of proliferating transit cell compartments
with self-renewal potential. First, in order to avoid insta-
bility, that is, uncontrolled increase in the size of a pro-
liferating transit population, the self-renewal capability of
a proliferating transit cell population must be limited (ie,
the value of αx must be < 1). Sustained values αx ≥ 1
will result in a condition of uncontrolled expansion of the
“X” compartment. The potential links between mecha-
nismsofself-renewalinstemcellandtransitcellcompart-
ments and the development and progression of cancers
have been recently discussed, both in concept and in re-
lation to disregulation of speciﬁc common pathways (eg,
wnt, bcl-2, notch, sonic hedgehog, and cell cycle regula-
tors p53, p21, etc) [113, 126].
Furthermore, if the number of cells entering the “X”
compartment from an upstream source (dNx/dt) in-
creases,theonlymechanismsofaccommodationtomain-
tain steady state (other than direct cell depletion by apop-
tosis) is to increase the activation rate of the transit pop-
ulation (a counter intuitive response), or to further de-
crease the value of αx in the transit compartment. Finally,
it is interesting to note that if dNx/dt does fall to zero as
a result of loss of function in the upstream compartment,
αx must increase to 1 to maintain the proliferating transit
cellpool.Thisincreaseinαx isthefunctionalequivalentof
the transit cell population in the “X” compartment func-
tionally occupying the upstream stem cell niche, even if it
does not physically move into the anatomic niche of the
upstream compartment. Both the requirement for lim-
ited self-renewal in proliferating transit cell populations
and the possibility of downstream populations function-
ally “reﬁlling” the loss of function in an upstream stem
cell niche have been proposed by previous authors [98].
CONCLUSIONS
This manuscript presents the rational development
of a cell-based modeling strategy for exploring the ki-
netic relationships within and between stem cell com-
partments and transit compartments within the muscu-
loskeletal system, particularly in bone formation and re-
modeling. We believe that these tools can be eﬀectively
appliedtodeﬁningandunderstandingeventsoftissuefor-
mation, repair, and remodeling, throughout embryonic
and fetal development and adult life. This modeling strat-
egy is built around quantiﬁable variables that can be used
to deﬁne the behavior of stem cell sets: cell number, ac-
tivation rate, migration, proliferation, and probabilities
of diﬀerentiation (or transit), self-renewal, and survival.
These variables are integrally related to, and in fact may
be used to, deﬁne the state of function and control the
expansion, contraction, and distribution of cell popula-
tions within each cell compartment and tissue through-
out life. In fact, these variables may be useful in deﬁning
the function or “state of health” of each stem cell or tissue
compartment.
Current techniques of quantitative histomorphome-
try in bone provide access to much of the cell-based data
thatisrequiredforthisapproach.However,currentmeth-
ods are dominated by predominantly matrix-based in-
formation deﬁned by assays of matrix volume, surface
area, and mineralization rate. Transition to a more cell-
based approach is currently time consuming, laborious,
and is limited by the lack of validated and reproducible
tools for identiﬁcation and quantitative assessment of low
abundancecellpopulations andtheirkinetic propertiesin
three dimensions. However, the diﬃculty associated with
collecting and analyzing data of this type does not dimin-
ish the central importance and fundamental biological
relevance of cell-level population kinetics to a quantita-
tive mechanistic understanding of settings of bone tissue2003:3 (2003) Connective Tissue Stem Cell Kinetics 189
formation, remodeling, and regeneration. In fact, similar
strategies should be applicable to all tissues.
High-resolutiondigitalimagingmodalitiesarerapidly
expanding the set of tools that are available for quan-
titative assay of cell sets in two dimensions (eg, digital
microscopy) and also three-dimensional tissue volumes
(eg, confocal microscopy, microCT, microPET, and mi-
croMRI) [128, 129]. Similarly, image processing tools for
rapid and reproducible quantitative characterization of
cell sets within these images are increasingly accessible.
We hope that presentation of this modeling strategy will
helptostimulateinnovationandthedevelopmentoftools
to optimize cell-based kinetic analysis. Of particular rel-
evance are unique markers (eg, presentation of unique
surface ligands or antigens, morphologic features, and
gene expression patterns) to assay cells within deﬁned tis-
sue volumes and compartments (Nx), and tools to deter-
mine the life-span (or half-life) of cells (lx) in these pop-
ulations. These parameters alone will allow calculation
of the theoretical rate at which new cells enter or leave
each cell compartment (dNx/dt). Knowledge of the num-
ber and identity of cells in the upstream compartment
(Nx−1) allows further insight into the kinetic parameters
operatingbetweenthetwocompartments(ie,theproduct
ARx−12µ
x−1Px). The relationship deﬁned by this product
caninturnbefurtherexploitedandalsotestedforvalidity
by assessment of the mitotic rate and prevalence of apop-
tosisandmarkersofdiﬀerentiationamongcellswithinthe
upstream compartment.
Coupled with a cell-based kinetic framework, histo-
logic analysis at a tissue level can become a powerful ve-
hicle with which to extract clinically relevant information
regarding the mechanism underlying the action of phar-
macologic agents with osteotropic eﬀects, and to charac-
terize these eﬀects in terms of quantitative changes in AR,
proliferation kinetics (µ), or diﬀerentiation (Pob) within
speciﬁc osteoblastic stem cell and transit cell compart-
ments. The eﬀects of extrinsic physical parameters (eg,
mechanical unloading or electromagnetic stimulation),
genomicvariation,ortargetedgeneticengineeringmaybe
similarly assessed. Investigation of time-oriented changes
in regional stem cell kinetics during embryonic and post-
natal development should also be accessible.
Finally, this strategy may be useful in analysis of mus-
culoskeletal tissue engineering strategies for the regenera-
tion,augmentation,orrepairofboneandothertissues.In
settings where a starting point is deﬁned by a tissue con-
taining a deﬁned set of seeded or local cells and the de-
sired endpoint is a tissue containing a diﬀerent set of cells,
the quantitative cell-based conceptual framework can be
used to deﬁne the speciﬁc functional biologic require-
ments needed from the seeded or local stem cell popu-
lation to achieve the desired result (ie, cell number, acti-
vation, proliferation, migration, diﬀerentiation, and sur-
vival). Similar concepts may also be applicable to tissue
engineering in other organ systems outside of bone and
musculoskeletal tissues.
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